FORUM
| Issue | Title | |
| Vol 1, No 2 (2023) | The first genome-edited cell product receives FDA approval | Abstract PDF (Rus) |
| P. I. Makarevich | ||
| 1 - 1 of 1 Items | ||
Section Details
Popular articles
Vol 2, No 2 (2024)
Vol 2, No 2 (2024)
Vol 2, No 2 (2024)
Vol 2, No 2 (2024)
Vol 2, No 2 (2024)
Vol 1, No 1 (2023)
Keywords
CAR-T-therapy
angiogenesis
cellular immunotherapy
chimeric antigen receptor
differentiation
endothelial cells
extracellular vesicles
gene therapy
genome editing
hereditary diseases
hormone sensitivity
mesenchymal stem cells
mesenchymal stromal cells
microRNA
regeneration
regenerative medicine
scientific communication
spheroids
stem cells
telomerase catalytic protein subunit
tissue and organ regeneration
119049, Russian Federtion, Moscow, Partijnyj per., 1, bld. 58, of. 716
Processing of personal data